Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R W Naeraa

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Acta Paediatrica Scandinavica|February 1, 1990
Standards for growth and final height in Turner's syndromeR W Naeraa, J Nielsen
Ugeskrift for Laeger|June 15, 1992
[Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences]R W Naeraa, J Nielsen, K W Kastrup
European Journal of Pediatrics|February 1, 1994
Growth hormone and 17 beta-oestradiol treatment of Turner girls--2-year resultsR W Naeraa, J Nielsen, K W Kastrup
BMJ (Clinical Research Ed.)|January 6, 1996
Prenatal and postnatal prevalence of Turner's syndrome: a registry studyC H Gravholt, S Juul, R W Naeraa, et al.
Journal of Clinical Epidemiology|February 25, 1998
Morbidity in Turner syndromeC H Gravholt, S Juul, R W Naeraa, et al.
Acta Paediatrica Scandinavica|August 1, 1990
Prediction of final height in Turner's syndrome. A comparative studyR W Naeraa, M Eiken, E G Legarth, et al.
Acta Paediatrica Scandinavica|August 1, 1990
Effect of oxandrolone on growth and final height in Turner's syndromeR W Naeraa, J Nielsen, I L Pedersen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population studyC H Gravholt, J Fedder, R W Naeraa, et al.
Ugeskrift for Laeger|May 19, 1997
[Prenatal and postnatal prevalence of Turner syndrome. A registry-based study]C H Gravholt, S Juul, R W Naeraa, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiolC H Gravholt, R W Naeraa, S Fisker, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Acta Paediatrica Scandinavica|February 1, 1990
Standards for growth and final height in Turner's syndromeR W Naeraa, J Nielsen
Ugeskrift for Laeger|June 15, 1992
[Treatment of girls with Turner's syndrome with growth hormone and estrogen--1-year experiences]R W Naeraa, J Nielsen, K W Kastrup
European Journal of Pediatrics|February 1, 1994
Growth hormone and 17 beta-oestradiol treatment of Turner girls--2-year resultsR W Naeraa, J Nielsen, K W Kastrup
BMJ (Clinical Research Ed.)|January 6, 1996
Prenatal and postnatal prevalence of Turner's syndrome: a registry studyC H Gravholt, S Juul, R W Naeraa, et al.
Journal of Clinical Epidemiology|February 25, 1998
Morbidity in Turner syndromeC H Gravholt, S Juul, R W Naeraa, et al.
Acta Paediatrica Scandinavica|August 1, 1990
Prediction of final height in Turner's syndrome. A comparative studyR W Naeraa, M Eiken, E G Legarth, et al.
Acta Paediatrica Scandinavica|August 1, 1990
Effect of oxandrolone on growth and final height in Turner's syndromeR W Naeraa, J Nielsen, I L Pedersen, et al.
The Journal of Clinical Endocrinology and Metabolism|September 22, 2000
Occurrence of gonadoblastoma in females with Turner syndrome and Y chromosome material: a population studyC H Gravholt, J Fedder, R W Naeraa, et al.
Ugeskrift for Laeger|May 19, 1997
[Prenatal and postnatal prevalence of Turner syndrome. A registry-based study]C H Gravholt, S Juul, R W Naeraa, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1997
Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17 beta-estradiolC H Gravholt, R W Naeraa, S Fisker, et al.
Pageof 2